Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-049446

Chief Executive Officer acquired 5,908 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ciechanover Isaac E. Chief Executive Officer 2017-08-15 Option exercise +5,908 737,767 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ciechanover Isaac E. Chief Executive Officer 2017-08-15 Option exercise · Restricted Stock Units −5,908 9,846 D: show line 2 in the form
Loading xslF345X03/doc4.xml…